tldrdailynews.com logo
Tag

Rescheduling

All articles tagged with #rescheduling

DOJ's partial rescheduling of cannabis leaves federal legalization unresolved
policy16 days ago

DOJ's partial rescheduling of cannabis leaves federal legalization unresolved

The DOJ moved certain marijuana products—from FDA-approved items to state-licensed medical cannabis—from Schedule I to Schedule III, a narrow step that allows medical prescriptions but does not legalize cannabis federally or for recreation. Enforcement remains discretionary, and ongoing lawsuits challenge the order, while states continue operating under a patchwork system with broad public support for legalization but no federal change on the horizon.

via USA Today|
#department-of-justice#federal-state-conflict#legalization
Congressional CRS: Medical Cannabis Rescheduling Is a Limited Federal Opening
policy20 days ago

Congressional CRS: Medical Cannabis Rescheduling Is a Limited Federal Opening

CRS says moving medical cannabis from Schedule I to III signals medical value and could allow some state-licensed medical cannabis businesses and researchers to operate with fewer federal barriers and may enable 280E tax deductions, but it does not fully legalize recreational marijuana or bring the entire state-legal industry into CSA compliance; many penalties remain under the CSA, and full compliance will depend on further federal action and upcoming hearings, with ongoing research and regulatory considerations plus an expedited DEA registration process for compliant medical-license holders.

via Marijuana Moment|
#crs#federal-law#marijuana
Partial cannabis rescheduling fuels federal policy confusion
politics26 days ago

Partial cannabis rescheduling fuels federal policy confusion

The Trump administration moved state-licensed medical cannabis products and FDA-approved cannabis products from Schedule I to Schedule III, a partial rescheduling that doesn’t fully normalize cannabis at the federal level. Experts say this is not a broad reclassification and hinges on future FDA decisions, leaving implementation unclear and raising questions about protections for patients, housing and employment, and equity for minority entrepreneurs. A June 29 DEA hearing on rescheduling adds to the uncertainty amid ongoing debate about alignment with the UN Single Convention and overall public support for full legalization.

via The Guardian|
#cannabis#dea#drug-policy
Tax Guidance Ahead as Marijuana Is Reclassified to Schedule III
politics1 month ago

Tax Guidance Ahead as Marijuana Is Reclassified to Schedule III

Federal officials say they will issue new tax guidance for the marijuana industry after the Trump administration reclassified cannabis so state-licensed medical cannabis moves to Schedule III while recreational cannabis remains Schedule I for now; the change is not a federal legalization but could allow medical cannabis businesses to deductions and credits previously blocked by IRS 280E. The guidance is expected to explain how expenses should be allocated for entities with both medical and recreational activities, with possible retrospective relief in some years, and comes as a summer hearing process considers broader rescheduling. Separately, the DOJ said rescheduling doesn’t change gun-rights considerations in a pending case, and Trump praised the medical benefits of cannabis.

via Marijuana Moment|
#280e#marijuana#politics
politics1 month ago

Trump reclassifies marijuana to Schedule III to boost medical research

The Trump administration moved to shift marijuana from Schedule I to Schedule III to expand medical research access, limited to FDA-approved products or state-legal medical cannabis, with an administrative hearing set for June 29 to speed broader rescheduling. The move, rooted in a December executive order, does not legalize cannabis federally but includes tax relief for cannabis companies and could lend legitimacy to regulated medical programs. Reactions are mixed: supporters praise the shift as overdue progress, while some Republicans and critics worry it may advance industry interests over public health.

via Politico|
#doj#fda#marijuana
Cannabis moved to Schedule III, easing research and banking while federal legalization remains off the table
politics1 month ago

Cannabis moved to Schedule III, easing research and banking while federal legalization remains off the table

The Trump administration moved cannabis from Schedule I to Schedule III under the DEA, easing federal research barriers and allowing FDA-approved products and state-licensed items to be treated as Schedule III, while opening banking access and tax deductions for cannabis businesses. An expedited June hearing will also consider formal reclassification back to Schedule I at the federal level, signaling a broader, cautious shift in federal cannabis policy without legalizing it federally.

via CNBC|
#banking#cannabis#politics
GOP Lawmaker Pushes 20-Year Timeline to Reschedule Marijuana
politics3 months ago

GOP Lawmaker Pushes 20-Year Timeline to Reschedule Marijuana

Rep. Andy Harris (R-MD) says the Justice Department should take about 20 years to reschedule marijuana from Schedule I to Schedule III, arguing that the process moves slowly and that internal DOJ disagreements may be delaying action, even as Trump’s order to accelerate the rule remains pending; other lawmakers indicate readiness to act when opportunities arise, while DOJ has offered little public comment amid shifting political dynamics such as redistricting.

via Marijuana Moment|
#cannabis-policy#congress#doj
Potential Impact of Marijuana Reclassification on Research and Policy
health-and-policy5 months ago

Potential Impact of Marijuana Reclassification on Research and Policy

President Trump signed an executive order to prompt the Department of Justice to reclassify marijuana from Schedule I to Schedule III, which could ease banking and tax issues for cannabis businesses and potentially influence future medical and recreational use policies, but it does not legalize marijuana federally or allow crossing state lines with it.

via Colorado Public Radio|
#cannabis-industry#federal-law#health-and-policy
The Who's Philadelphia Concerts Postponed Without Explanation
entertainment9 months ago

The Who's Philadelphia Concerts Postponed Without Explanation

The Who's Thursday concert in Philadelphia has been postponed due to band members contracting a cold/flu, with plans to reschedule. The band, known for their historic role in the British Invasion, has a long history in Philadelphia and is currently on their North American farewell tour. Ticket holders are advised to wait for rescheduling updates or request refunds if the event is canceled.

via inquirer.com|
#concert-postponement#entertainment#philadelphia